Zoetis reported Q1 2026 revenue of $2.3B (+1.9% YoY), missed analyst consensus of $2.3B by $39.4M. Diluted EPS came in at $1.53 (+3.4% YoY), missed the $1.60 consensus by $0.07. Zoetis reports across 3 business segments, led by Companion Animal Products, Livestock Products, and Animal Health Diagnostics.
Trailing eight quarters through Q1 2026
Common questions about Zoetis's Q1 2026 earnings report.
Zoetis (ZTS) reported Q1 2026 earnings on May 7, 2026 before market open.
Zoetis reported revenue of $2.3B and diluted EPS of $1.53 for Q1 2026.
Revenue missed the consensus estimate of $2.3B by $39.4M. EPS missed the consensus estimate of $1.60 by $0.07.
Compared to the same quarter a year prior, revenue grew 1.9% from $2.2B a year earlier and diluted EPS grew 3.4% from $1.48.
You can read the 8-K earnings release (0001555280-26-000021) and the 10-Q periodic report (0001555280-26-000024) directly on SEC EDGAR. The filing index links above go to sec.gov.